Zeke LP’s DexCom DXCM Stock Holding History

Zeke LP’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$600K	Sell	60,000 -300,000	-83%	-$3.07M	2.15%	23
2014 Q2	$3.57M	Buy	360,000 +20,000	+6%	+$177K	5.52%	2
2014 Q1	$3.52M	Sell	340,000 -60,000	-15%	-$620K	4.74%	3
2013 Q4	$3.54M	Hold	400,000	–	–	4.22%	3
2013 Q3	$2.82M	Sell	400,000 -40,000	-9%	-$253K	3.31%	7
2013 Q2	$2.47M	Buy	+440,000	New	+$2.11M	3.23%	9

Other funds holding DXCM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Zeke LP's DXCM Position: Q3 2014 in Review

Zeke LP reduced its DexCom (DXCM) stake by 83% in Q3 2014, selling an estimated $3.07M and leaving 60,000 shares worth $600K. The position accounts for 2.15% of the portfolio, ranked #23.

Zeke LP first reported a position in DXCM in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.57M in Q2 2014. 200 funds tracked by Wall St. Rank hold DXCM as of Q3 2014.

Zeke LP held 60,000 shares of DexCom worth $600K as of Q3 2014.
Zeke LP sold 300,000 DexCom shares in Q3 2014, an estimated $3.07M.
DexCom made up 2.15% of Zeke LP's portfolio in Q3 2014, its #23 holding.
Zeke LP first reported a position in DexCom in Q2 2013 and has held it in 6 quarters since.
Zeke LP's DexCom position peaked at $3.57M in Q2 2014.
200 funds tracked by Wall St. Rank held DexCom as of Q3 2014.

Based on Zeke LP's 13F filing for Q3 2014, filed 28 Oct 2014.